Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|September 7, 2025
Amrubicin monotherapy for refractory, relapsed, small cell lung cancer in elderly patientsMasashi Takemoto, Shiori Kinoshita, Kazuki Yamada, et al.
Molecular Cancer Therapeutics|May 1, 2008
MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancerTetsuya Oguri, Hiroaki Ozasa, Takehiro Uemura, et al.
Respirology Case Reports|August 30, 2021
Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancerTakehiro Uemura, Kensuke Fukumitsu, Ken Maeno, et al.
Experimental and Therapeutic Medicine|October 13, 2012
Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literatureMakoto Nakao, Tetsuya Oguri, Mikinori Miyazaki, et al.
Oncology Reports|December 17, 2008
ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancerYuji Bessho, Tetsuya Oguri, Hiroaki Ozasa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 4, 2011
C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicinOsamu Takakuwa, Tetsuya Oguri, Hiroaki Ozasa, et al.
The American Journal of Hospice & Palliative Care|December 25, 2012
Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancerOsamu Takakuwa, Tetsuya Oguri, Ken Maeno, et al.
Anticancer Research|May 7, 2013
Thymidylate synthase gene copy number as a predictive marker for response to pemetrexed treatment of lung adenocarcinomaDaishi Kasai, Hiroaki Ozasa, Tetsuya Oguri, et al.
Cancer Science|May 16, 2014
Significance of c-MET overexpression in cytotoxic anticancer drug-resistant small-cell lung cancer cellsHiroaki Ozasa, Tetsuya Oguri, Ken Maeno, et al.
Anticancer Research|September 27, 2015
Reversal of c-MET-mediated Resistance to Cytotoxic Anticancer Drugs by a Novel c-MET Inhibitor TAS-115Eiji Kunii, Hiroaki Ozasa, Tetsuya Oguri, et al.
Pageof 11